Immage Biotherapeutics Corp. (IMMG)

OTC • Currency in USD

$0.00

0.00%

Last Update: 7 Jul 2025, 13:39

$152.00

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

$0.00 - $0.00

52 Week Range

IMMG Stock Price Chart

Explore Immage Biotherapeutics Corp. interactive price chart. Choose custom timeframes to analyze IMMG price movements and trends.

There is nothing to show.

IMMG Company Profile

Discover essential business fundamentals and corporate details for Immage Biotherapeutics Corp. (IMMG) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Financial - Conglomerates

IPO Date

2 Dec 2022

Employees

3.00

Website

https://www.immagebio.com

CEO

Zhi Cong Mou

Description

Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.

IMMG Financial Timeline

Browse a chronological timeline of Immage Biotherapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

IMMG Stock Performance

Access detailed IMMG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.